| Dr Duc Minh Bui, | |
|
4095 Evergreen Village Sq Ste 110, San Jose, CA 95135-1747 | |
| (408) 532-1308 | |
| Not Available |
| Full Name | Dr Duc Minh Bui |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 4095 Evergreen Village Sq Ste 110, San Jose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023190089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 11044T (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Duc Minh Bui, 4095 Evergreen Village Sq Ste 110, San Jose, CA 95135-1747 Ph: (408) 532-1308 | Dr Duc Minh Bui, 4095 Evergreen Village Sq Ste 110, San Jose, CA 95135-1747 Ph: (408) 532-1308 |
News Archive
A recent study conducted by the EU Horizon 2020-funded ParaFishControl project aimed to demonstrate the absence of zoonotic parasitic worms in European farmed fish, specifically in gilthead sea bream, European sea bass, turbot, Atlantic salmon, rainbow trout and common carp.
Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc., a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years.
A University of Colorado Cancer Center study published in this month's Proceedings of the National Academy of Sciences describes the activity of a recently discovered communication molecule of the body's immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system: IL-37 inhibits the ability of the immune system to recognize and target new antigens.
BioMS Medical Corp has announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients.
› Verified 4 days ago
Cyndi C Lee, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1558 S Bascom Ave, San Jose, CA 95125 Phone: 408-371-5180 | |
Christopher Ngo, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1080 S White Rd, A, San Jose, CA 95127 Phone: 408-272-3002 | |
Kari Tran, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2380 Montpelier Dr, Ste 300, San Jose, CA 95116 Phone: 408-272-3706 Fax: 408-254-4094 | |
Shinmori Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 214 Jackson St, San Jose, CA 95112 Phone: 408-293-3730 Fax: 408-293-2131 | |
Ms. Cecilia K Imamura, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55 E Julian St, San Jose, CA 95112 Phone: 408-918-2618 Fax: 408-795-1129 | |
Shirley Quicho, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 590 Blossom Hill Rd, San Jose, CA 95123 Phone: 408-227-2020 Fax: 206-338-0411 |